Tag: McGovern Medical School

Patients with past cancer history not associated with higher risk of COVID-19-related death or hospitalization

sarah JonasResearch Results

Patients diagnosed with cancer more than one year ago and those not receiving active treatment were no more vulnerable to worse COVID-19 outcomes than patients without cancer, according to a new study led by UTHealth Houston.

The power of vitamin D: What experts already know (and are still learning) about the ‘sunshine vitamin’

sarah JonasFeature

It’s no secret that vitamin D is critical to balancing many areas of health. But from pediatric broken bones to cluster headaches, physicians and scientists at The University of Texas Health Science Center at Houston (UTHealth Houston) are still learning just how powerful the so-called “sunshine vitamin” is.

McCullough wins AHA/ASA Neuroscience Visionary Award

sarah JonasAnnouncement

Her scientific leadership in the laboratory studying sex differences in stroke severity and outcomes is among the reasons why Louise McCullough, MD, PhD, received the 2021 C. Miller Fisher, MD Neuroscience Visionary Award from the American Heart Association/American Stroke Association (AHA/ASA).

Family of proteins offers promise as ischemic stroke treatment, preclinical trial finds

sarah JonasResearch Results

Boosting a family of naturally occurring proteins that dampens inflammation in the body has been shown to be effective in reducing damage from an ischemic stroke, according to preclinical researchers at The University of Texas Health Science Center at Houston (UTHealth).

Oderich joins UTHealth as Chief of Vascular and Endovascular Surgery

sarah JonasAnnouncement

Gustavo Oderich, MD, FACS, a noted leader in the field of vascular and endovascular surgery, has been named chief of the vascular surgery division with the Department of Cardiothoracic and Vascular Surgery at The University of Texas Health Science Center at Houston (UTHealth). He will serve as professor of vascular and endovascular surgery at McGovern Medical School at UTHealth and director of the Advanced Endovascular Aortic Program.

Team is first in Texas to join NIH study investigating efficacy of convalescent plasma for COVID-19

sarah JonasFeature

Using a multimillion-dollar grant from the NIH, physician-scientists at The University of Texas Health Science Center at Houston (UTHealth) will investigate whether convalescent plasma infusions can prevent the progression of COVID-19 in one of the first randomized clinical trials in the country.